. Author manuscript; available in PMC: 2011 Aug 1.

Published in final edited form as: J Autoimmun. 2010 Feb 20;35(1):33–44. doi: 10.1016/j.jaut.2010.01.003

Table 1.

Clinical evaluation of EAE induced after transfer of in vitro-activated MOG_35–55-specific CD8+T cells (cumulative data from three experiments).

Condition	Experiment duration (day)	Incidence	Mortality	Onset (day)	Time to peak (day)	Peak score	Cumulative score	Average clinical score	Outcome	Grade of remission
Disease control	30	13/13	2/13	9.69	11.38	3.77	65.15	2.20	3.27	0.50
OVA-CD8+	30	12/12	2/12	9.92	13.08	4.38	78.46	2.53	3.42	0.96
MOG-CD8+	30	11/11	0/11	11.91	13.09	2.77 ^*	36.73 ^*	1.20 ^*	1.00 ^*	1.77 ^*

MOG-CD8+ clinical data was statistically compared to OVA-CD8+ data or disease control.

p ≤ 0.05.